Journal Article Summary
The article discusses pulmonary veno-occlusive disease (PVOD), a rare and serious form of pulmonary arterial hypertension (PAH) that is often misdiagnosed. Unlike other types of PAH, PVOD has a poor prognosis due to its progressive nature and the risk of severe pulmonary edema from PAH-targeted therapies. The study highlights the importance of accurate diagnosis and treatment options, as lung transplantation is typically the only effective solution for PVOD patients. The authors present two cases where patients initially diagnosed with idiopathic PAH were later confirmed to have PVOD through genetic testing.
In this study, the authors examined two male patients who were initially misdiagnosed with idiopathic PAH but later found to have biallelic mutations in the EIF2AK4 gene, confirming PVOD. Both patients received PAH-targeted therapy, including Ambrisentan and tadalafil, and showed significant improvement in their symptoms over a follow-up period of more than one year, without developing pulmonary edema. The findings suggest that some patients with PVOD may respond positively to PAH-targeted treatments, challenging the notion that these therapies are contraindicated in PVOD cases.
However, the study has limitations, including the small number of cases and the lack of long-term data on the safety and efficacy of PAH-targeted therapies in PVOD. Patients and caregivers should be cautious, as the risk of pulmonary edema remains high with these treatments, and they should consult healthcare professionals for personalized advice. Genetic testing for EIF2AK4 mutations may be beneficial for patients suspected of having PVOD, as it can help differentiate this condition from other forms of PAH and guide appropriate management strategies.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Zhang Li, Wang Yao, Zhang Ruifeng. Good response to pulmonary arterial hypertension-targeted therapy in 2 pulmonary veno-occlusive disease patients. Medicine 2021. DOI: 10.1097/MD.0000000000027334. PMID: 34731104. PMCID: PMC8519212.
Featured Pill Pals Product
Tadalafil 5 MG Tablets --- Generic for Cialis --- Ajanta Pharma
Tadalafil 5 MG Tablets ā Generic for Cialis ā Ajanta Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
